Otsuka Pharmaceutical to Introduce New Dosage Form for Its bronchodilator Meptin.Tokyo, Japan, Aug 12, 2005 - (JCNN JCNN Japan Corporate News Network ) - Otsuka Pharmaceutical announced on August 11 that it will launch Meptin Clickhaler 10MU/g, a new dosage form for its Meptin series of bronchodilator bronchodilator /bron·cho·di·la·tor/ (-di´la-ter) 1. expanding the lumina of the air passages of the lungs. 2. an agent which causes dilatation of the bronchi. , on September 2. The new product, which fills Clickhaler, a powder inhaler inhaler /in·hal·er/ (in-hal´er) 1. an apparatus for administering vapor or volatilized medications by inhalation. 2. ventilator (2). in·hal·er n. offered by Innovata Biomed, with Meptin dry powder, will be a new dosage choice and help improve patients' quality of life. Meptin, a beta-2 agonist developed by Otsuka Pharmaceutical, is currently marketed in 13 countries worldwide. Ten different dosages forms including tablet, syrup and dry syrup are available. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion